VARIABLE | CONTROL (n = 19) | PATIENTS (n = 30) | p value |
---|---|---|---|
Female n (%) | 10 (53) | 17 (57) | 0.86 |
Current Age (years) | 32 (26-39) | 32 (23-42) | 0.96 |
Height (cm) | 171 ±6.3 | 169 ±9.2 | 0.3 |
Weight (kg) | 67 ±8 | 75 ±21 | 0.1 |
NYHA I / II | 19 (100) / 0 (0) | 28 (93) / 2 (7) | 0.44 |
Systolic BP (mmHg) | 120 ±10 | 123 ±15 | 0.46 |
Diastolic BP (mmHg) | 73 ±7 | 75 ±11 | 0.6 |
AML n (%) | Â | 2 (7) | Â |
ALL n (%) | Â | 23 (77) | Â |
Wilms n (%) | Â | 5 (17) | Â |
Age at diagnosis (years) | Â | 4.6 (1-15) | Â |
Time since chemo (years) | Â | 25 (16-32) | Â |
Anth Dose (mg/m2) | Â | 220 (90-370) | Â |
Radiotherapy n (%) | Â | 24 (80) | Â |
BMT n (%) | Â | 7 (23) | Â |
CARDIOVASCULAR MR DATA | Â | Â | Â |
LVEDV index (ml/m2) | 72 ±8 | 73 ±12 | 0.92 |
LVESV index (ml/m2) | 25 ±6 | 30 ±8 | *0.05 |
LV EF (%) | 65 ±5 | 61 ±6 | *0.01 |
LV mass index (g/m2) | 60 ±10 | 58 ±11 | 0.53 |
RVEDV index (ml/m2) | 76 ±8 | 69 ±12 | 0.10 |
RVESV index (ml/m2) | 29 ±6 | 28 ±14 | 0.68 |
RV EF (%) | 62 ±4 | 63 ±5 | 0.39 |
MAPSE (cm) | 15 ±1.1 | 13 ±2.6 | *0.02 |
Left Atrial Area (cm2) | 20 ±2.3 | 21 ±3.1 | 0.47 |
Native myocardial T1 | 960 ±37 | 967 ±37 | 0.53 |
Native blood pool T1 | 1484 ±76 | 1463±118 | 0.50 |
Extracellular volume fraction |  | 0.26 ±0.04 |  |
Focal LGE | Â | 2 (7) | Â |